drugset / Trial / NCT00878670

Investigation of Efficacy and Safety of EPOGAM

NCT00878670

Phase 4 Completed 23 enrolled Max Zeller Soehne AG
NaSingle-groupOpen-labelTreatment

Summary

In this study it will be investigated if patients with atopic dermatitis responding to EPOGAM treatment, show a significant increase of dihomo-gamma-linolic acid in the blood.

Timeline

Start
2009-03
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Evening Primrose Oil Unknown 4 g Oral
Subject Evening Primrose Oil Unknown 6 g Oral